The US FDA has approved the first biosimilar version of AstraZeneca/Alexion’s Soliris therapy for paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic ...
The first biosimilars of AstraZeneca/Alexion's blockbuster complement C5 inhibitor Soliris have been launched in the US at a discount to the brand. Both Amgen's Bkemv and Teva/Samsung Bioepis' Epysqli ...
When Apple released iOS 26, it switched up the Lock Screen so that the clock can be expanded to fill more of the display, making it easier to read. This can be done in Customize mode thanks to a drag ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results